Uterine Leiomyoma in Kinshasa, the Capital of the Democratic Republic of Congo

Authors

  • Ingala P Department of Obstetrics and Gynecology, University of Kinshasa Hospital, Kinshasa, 00243, Democratic Republic of Congo
  • Lepira F Department of Internal Medicine, University of Kinshasa, Kinshasa, 00243, Democratic Republic of Congo
  • Muhindo S Department of Obstetrics and Gynecology, University of Kinshasa Hospital, Kinshasa, 00243, Democratic Republic of Congo
  • Mputu L Department of Obstetrics and Gynecology, University of Kinshasa Hospital, Kinshasa, 00243, Democratic Republic of Congo

Keywords:

Uterine Leiomyoma -Particularities- Democratic Republic of Congo.

Abstract

The aim of the present study was to determine the particularities of Uterine Leiomyomas among Congolese in Kinshasa the capital of the Democratic Republic of Congo (DRC) in the present conditions of medical practices. A sample of 644 patients with uterine leiomyoma were selected from 6440 cases of uterine leiomyoma among 30395 patients treated in gynecology units of three medical institutions of Kinshasa (University hospital of Kinshasa, Saint joseph hospital and Edith medical center) from January Ist ,2003 to December 31,2012. The study is a descriptive one. The following variables were taken account: medical history [age, age at menarche, parity, education, civil state, history of UL, symptoms and body mass index (BMI)]; lifestyle (smoking, alcohol intake); ultrasounds characteristics; hysteroslpingographies characteristics, treatment, and direct cost of treatment. Statistical analysis were performed using Excel 12.0 software. Demographic, clinical, ultrasound, hysterosalpingography and treatment data were evaluated using descriptive statistics: mean, standard deviation (SD), and percentage (%) as appropriate. The frequency of uterine leiomyoma was 21, 18%. That one concern mainly patients at 35 years old or more [49, 6% (35-44years), ?45years (20, 6%)], singles (70, 4%), null parous (59,4%), having a high level of study (university: 54, 6%), history of UL (56, 7%), and alcohol intake (75, 5%). Hemorrhage (33, 2%) and pelvic pain (31, 6%) are the most frequent expression of those tumors. The most of those patients have excess weight (43, 1%) or obesity (46, 5%). The majority of uterine leiomyoma was corporeal (82, 9%) intramuscular (42, 4%) and their number didn’t overtake five by patient (70, 8%) in majority of cases. Majoration of the uterine cavity (46, 5%) and Fallopian tubes obstructions (30, 6%) are the most frequent abnormalities in hysterosalpingography. Myomectomy is the main treatment (65, 2%). The mean of direct cost were 803$ USA and 884$ USA for myomectomy and hysterectomy respectively.

References

[1]. Sparic R., Mirkovic L., Malvasi A., Tinelli A. Epidemiology of uterine myomas: A Review Int J Fertil Steril. 2016; 9:424-35.
[2]. Flake GP., Andersen J., Dixo D. Etiology and Pathogenesis of uterine leiomyoma: a review.Environ Health Perfect. 2003; 11:1037-1054.
[3]. Baird DD., Dunson DB., Hill RC. Cousins D., Schectman JM. High cumulative incidence of Uterine Leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol.2003 Jan; 188(1):100-7.
[4]. Catherino WH., Eltoukhi HM., Al-Hendy. Racial and ethnic differences in the pathogenesis and clinical manifestation of uterine leiomyoma. Semin Reprod Med. 2013; 31151:370-379
[5]. Marshall LM., Spiegelman D., Barbieri RL. Goldman ME., Manson JE et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gnyecol. 1997; 90: 967-973.
[6]. Parker W.H. “Etiology, symptomatology, and diagnosis of uterine myomas”. Fertility and Sterility. 2007; .87:725-736.
[7]. Heba M. Eltoukhi., Monica N. Modi., Meredith Weston., Alicia Y.Amonstrong., Elizabeth A.Stewart. The Health Disparities of Uterine Fibroids for African Women: A Public Health Issue. Am J Obstet Gynecol.2014 Mar; 210(3):194-199.
[8]. Lauren A Wise., Julie Palmer., Elizabeth A Stewart., Lynn Rosenberg. Age-Specific Incidence Rates for Self-Reported Uterine Leiomyomata in the Black Women’s Health Study. Obstet Gyenecol. 2005 Mar; 105 (3): 563-568.
[9]. Muberuka. Devenir des femmes zaïroises après myomectomie. Mémoire de fin de spécialisation en Médecine. Faculté de Médecine Université de Kinshasa 1979.
[10]. Mundyo M. Devenir gynécologique et obstétrical après myomectomie aux cliniques universitaires de Kinshasa. Mémoire de fin de spécialisation. Faculté de médecine.Université de Kinshasa, 1984.
[11]. Dia A., Beye SB., Dangou JM., Dieng M., Woto gaye., Toure CT. Uterine Leiomyoma at the surgical department of the Teaching Hospital of Dakar. Report of 140 cases operated in two years. Dakar Med. 2003; 48(2):72-6.
[12].Obed JY., Bakob B., Usman SD., Moruppa JY., Kadas S. Uterine Fibroids: risk of occurrence after myomectomy in Nigeria population. Arch Gynécol Obstet. 2011 Feb; 283(2):311-5.
[13]. Fernandez H., Buffet CN., Allouche S. Prevalence of Uterine Fibroid in France and impact in quality of life : results of survey among 2500women between 30-55years. J Gyneco Obst Biol Reprod, 2014 Nov; 43(9):721-7.
[14]. Downes E., Sikri A., Gilabert-Estelles J., Rolge SC., Dodd SL., Maroulis C., Subramanian D. Eur J Obstet Gynecol Reprod Biol. 2010 Sep;152(1):96-102.
[15]. Rongières C. Recommandations pour la pratique Clinique: Epidémiologie du fibrome, facteurs de risque et fréquence. Impact en santé publique. Gynécol Obstet Biol Reprod 1999; 28:701-706.
[16]. Adama Hongebla A, Modji S, Aboubakari A, Wonegouk, Akpadza K. Aspects epidemiologiques et chirurgucaux de fibromes uterins opérés à l’hopital du district de Lomé. J rech Sci Univer Lomé 2012 ; serie D ; 14(1) :131-137.
[17]. Windham GC, Elkin E, Fenster L, et al. Ovarian hormones in premenopausal women: variation by demographic, reproductive and menstrual cycle characteristics. Epidemiology 2002; 13:675-84.
[18]. Bernstein L, Pike MC,Ross RK ,et al. Estrogen and sex hormone-binding levels in nulliparous and parous women. J Natl Cancer Inst1985; 74: 741-5.
[19]. Nagata C., Nakamura K., Oba S., Hayshi M., Takeda N., YasudaK. Association of intakes of fat , dietary fibre,soya isoflavones and alcohol with uterine fibroids in Japanese women. Br J Nutr. 2009 May; 101(10): 1427-31.
[20]. Yanq Y., He Y., Zenq Q., Li S. Association of body size and body fat distribution with uterine fibroids among Chinese women. J Womens Health (Larchmt). 2014 Jul;23(7): 619-26.
[21]. Hye-Kyung Na., Ja Young Lei. Molecular Basis of Alcohol-Related Gastric and Colon Cancer.Int J Mol Sci.2017 Jun; 18(6):1116. Publish online 2017 May 24.doi:10 3390/ijms18061116.
[22]. Shikora SA., Niloff JM., Bistrian BR., Forse RA., Blackbun GL. Relationship between obesity and uterine leiomyomata. Nutrition.1991 Jul-Aug; 7(4): 251-5.
[23]. Zimmermann A., Bernuit D., Gerlinger C., Schaefers M., Geppert K. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Women Health. 2012; 12:6-16.
[24]. Okogbo FO, Ezechi OC, Loto OM, Ezeobi PM. Uterine leiomyomata in south western Nigeria: a clinical study of presentations and management outcome. African Health Sciences 2011; 2: 271-278.
[25]. Nourelhouda Chalal., Abbassia Demmouche. Profil épidemiologique des fibromes utérins dnas la region de Sidi Bel Abbes,Algeria. Pan Afr Med J. 2013; 15:7.
[26]. Muhindo S. Profile of patients with uterine myomas in a population of infertile women in Kinshasa. Memory of end of specialization. 2013; Faculty of Medicine University of Kinshasa.
[27]. Kiquli-Malwadde E., Byanyima RK.Structural findings at hysterosalpingigraphy in patients with infertility at two private clinics in Kampala, Uganda. Afr Health Sci. 2004 Dec; 4(3): 178-81.
[28]. Nzau NE., Mboloko E., Tandu-Umba NFB., Lokengo LD. Hystérectomie aux cliniques universitaires de Kinshasa: de 2002-2010. Médecine de l’Afrique noire. 2012; 59:221-230.
[29]. Gante I., Medieros- Borges C., Aquas F. Hysterectomy in Portugal (2000-2014): what has changed? Eur J Obstet Gynécol Reprod Biol. 2017; 208:97-102.
[30]. Cravello L., Isnardi M., Violin G., Duthilleul A., Sambuc R et al. Evaluation du c?ut direct hospitalier et extra hospitalier de l’hystéroscopie opératoire et de l’hystérectomie vaginale. Journal de gynécologie obstétrique et biologie de la reproduction. 1999; 28:335
[31]. Soliman AM., Yang H., Du EX., Kellar SS., Winkel C. The direct and indirect cost of uterine fibroid tumors; a systematic review of the literature between 2000 and 2013. Am J Obstet Gynecol. 2015; 213:141-60.
[32]. Cardozo ER M.D., Clark AD., MD., Nicole James H.Segars. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet.2012; 206:211.e1-211.e9.

Downloads

Published

2017-12-10

How to Cite

P, I., F, L., S, M., & L, M. (2017). Uterine Leiomyoma in Kinshasa, the Capital of the Democratic Republic of Congo. American Scientific Research Journal for Engineering, Technology, and Sciences, 38(2), 68–76. Retrieved from https://asrjetsjournal.org/index.php/American_Scientific_Journal/article/view/3669

Issue

Vol. 38 No. 2 (2017)

Section

Articles

License

Authors who submit papers with this journal agree to the following terms.